Bempedoic acid
Esperion
[]
clear outcomes trial shows that bempedoic acid reduces ldl by about 30 mg/dl in statin intolerant pts stroke/mi/vasc death lower with treatment by 15% (1.3% absolute). no diff in all cause mortality. new option for stroke pts intolerant of statins #acc23 
Stroke neurologist and researcher. Stewart J. Greenebaum Endowed Professor of Stroke Neurology at U Maryland. Sports enthusiast. Views are my own